Switching treatments in haemophilia: is there a risk of inhibitor development?

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 4, 2015-04 ,pp. : 284-289

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved prediction of inhibitor development in previously untreated patients with severe haemophilia A

By  

HAEMOPHILIA, Vol. 21, Iss. 2, 2015-03 ,pp. : 227-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk factors associated with the development of thrombocytopenia in patients who received linezolid therapy

By Takahashi Yoshiko   Takesue Yoshio   Nakajima Kazuhiko   Ichiki Kaoru   Tsuchida Toshie   Tatsumi Sumiyo   Ishihara Mika   Ikeuchi Hiroki   Uchino Motoi  

Journal of Infection and Chemotherapy, Vol. 17, Iss. 3, 2011-06 ,pp. : 382-387

Springer Publishing Company

Access to resources Recommend Favorite

P069: Risk factors associated with type 2 diabetes mellitus in patients with chronic hepatitis B: a cross‐sectional study with pair‐matched controls

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 54-55

John Wiley & Sons Inc

Access to resources Recommend Favorite

Finasteride Adherence-Associated Factors in Chinese Benign Prostatic Hyperplasia Patients

By  

Urologia Internationalis, Vol. 88, Iss. 2, 2011-12 ,pp. : 177-182

Karger

Access to resources Recommend Favorite